0001779994-19-000001.txt : 20190619 0001779994-19-000001.hdr.sgml : 20190619 20190618195350 ACCESSION NUMBER: 0001779994-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20190619 DATE AS OF CHANGE: 20190618 EFFECTIVENESS DATE: 20190619 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Remiges BioPharma Fund II, LP CENTRAL INDEX KEY: 0001779994 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-342260 FILM NUMBER: 19904836 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-401-2136 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001779994 Remiges BioPharma Fund II, LP ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 617-401-2136 CAYMAN ISLANDS None None Other Cayman Islands exempted limited partnership true 2019 n/a Remiges BioPharma Fund GP II, Inc. One Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director General Partner of the Issuer (the General Partner) Walter Olesiak 404 Underhill Road Cambridge MA MASSACHUSETTS 02142 Director Secretary and COO of the General Partner Taro Inaba 1-13-9-1809 Kudankita Chiyoda-ku, Tokyo M0 JAPAN 102-0073 Director President, Treasurer and Director of the General Partner Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false true false true false 0 95000000 0 95000000 false 0 0 0 0 The Issuer is obligated to pay a management fee to the General Partner (or an affiliate thereof). false Remiges BioPharma Fund II, LP /s/ Walter Olesiak Walter Olesiak COO and Secretary of the General Partner 2019-06-18